ROSSI, GIOVANNI
ROSSI, GIOVANNI
100007 - Dipartimento di Medicina interna e specialità mediche
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients
2022-01-01 Marconi, Silvia; Croce, Michela; Chiorino, Giovanna; Rossi, Giovanni; Guana, Francesca; Profumo, Aldo; Ostano, Paola; Alama, Angela; Longo, Luca; De Luca, Giuseppa; Dono, Mariella; Dal Bello, Maria Giovanna; Ponassi, Marco; Rosano, Camillo; Romano, Paolo; Cavalieri, Zita; Grassi, Massimiliano; Tagliamento, Marco; Zullo, Lodovica; Venturi, Consuelo; Dellepiane, Chiara; Mastracci, Luca; Bennicelli, Elisa; Pronzato, Paolo; Genova, Carlo; Coco, Simona
Afatinib and Erlotinib in the treatment of squamous-cell lung cancer
2018-01-01 Tagliamento, M.; Genova, C.; Rijavec, E.; Rossi, G.; Biello, F.; Dal Bello, M. G.; Alama, A.; Coco, S.; Boccardo, S.; Grossi, F.
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer
2019-01-01 Carbone, Federico; Grossi, Francesco; Bonaventura, Aldo; Vecchié, Alessandra; Minetti, Silvia; Bardi, Nicholas; Elia, Edoardo; Ansaldo, Anna Maria; Ferrara, Daniele; Rijavec, Erika; Dal Bello, Maria Giovanna; Biello, Federica; Rossi, Giovanni; Tagliamento, Marco; Alama, Angela; Coco, Simona; Spallarossa, Paolo; Dallegri, Franco; Genova, Carlo; Montecucco, Fabrizio
CIMAvax-EGF, a therapeutic non-small cell lung cancer vaccine
2018-01-01 Tagliamento, M.; Rijavec, E.; Barletta, G.; Biello, F.; Rossi, G.; Grossi, F.; Genova, C.
Comparison between 18F-FDG-PET- and CT-based criteria in non-small cell lung cancer (NSCLC) patients treated with Nivolumab
2020-01-01 Rossi, Giovanni; Bauckneht, Matteo; Genova, Carlo; Rijavec, Erika; Biello, Federica; Mennella, Simone; Dal Bello, Maria Giovanna; Cittadini, Giuseppe; Bruzzi, Paolo; Piva, Roberta; Ceriani, Valentina; Sambuceti, Gianmario; Lopci, Egesta; Morbelli, Silvia; Grossi, Francesco
Current state of the art and future perspectives with immunotherapy in the management of small cell lung cancer
2021-01-01 Rijavec, E.; Genova, C.; Biello, F.; Rossi, G.; Indini, A.; Grossi, F.
Exploring Response to Immunotherapy in Non-Small Cell Lung Cancer Using Delta-Radiomics
2022-01-01 Barabino, E.; Rossi, G.; Pamparino, S.; Fiannacca, M.; Caprioli, S.; Fedeli, A.; Zullo, L.; Vagge, S.; Cittadini, G.; Genova, C.
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy
2022-01-01 Grottoli, Melania; Carrega, Paolo; Zullo, Lodovica; Dellepiane, Chiara; Rossi, Giovanni; Parisi, Francesca; Barletta, Giulia; Zinoli, Linda; Coco, Simona; Alama, Angela; Marconi, Silvia; Parodi, Monica; Orecchia, Paola; Bassi, Sara; Vitale, Massimo; Mingari, Maria Cristina; Pfeffer, Ulrich; Genova, Carlo; Pietra, Gabriella
Immunotherapy in Adolescents and Young Adults: What Remains in Cancer Survivors?
2021-01-01 Tanda, E. T.; Croce, E.; Spagnolo, F.; Zullo, L.; Spinaci, S.; Genova, C.; Rossi, G.
Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer
2017-01-01 Rijavec, E.; Genova, C.; Barletta, G.; Biello, F.; Rossi, G.; Tagliamento, M.; Dal Bello, M. G.; Coco, S.; Vanni, I.; Boccardo, S.; Alama, A.; Grossi, F.
Liquid biopsy in non-small cell lung cancer: Highlights and challenges
2020-01-01 Rijavec, E.; Coco, S.; Genova, C.; Rossi, G.; Longo, L.; Grossi, F.
Metabolic parameters as biomarkers of response to immunotherapy and prognosis in non-small cell lung cancer (Nsclc): A real world experience
2021-01-01 Monaco, L.; Gemelli, M.; Gotuzzo, I.; Bauckneht, M.; Crivellaro, C.; Genova, C.; Cortinovis, D.; Zullo, L.; Ammoni, L. C.; Bernasconi, D. P.; Rossi, G.; Morbelli, S.; Guerra, L.
Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds
2019-01-01 Tagliamento, M.; Genova, C.; Rossi, G.; Coco, S.; Rijavec, E.; Dal Bello, M. G.; Boccardo, S.; Grossi, F.; Alama, A.
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature
2023-01-01 Boutros, A; Bottini, A; Rossi, G; Tanda, E T; Spagnolo, F; Barletta, G; Croce, E; Fava, P; Parisi, A; De Rosa, F; Palla, M; Marconcini, R; Ferrari, M; Grandis, M; Spallarossa, P; Sarocchi, M; Arboscello, E; Del Mastro, L; Lambertini, M; Pronzato, P; Genova, C
New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients
2016-01-01 Del Mastro, L; Rossi, Giovanni; Lambertini, M; Poggio, F; Pronzato, P
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer
2016-01-01 Genova, C.; Rijavec, E.; Biello, F.; Rossi, G.; Barletta, G.; Dal Bello, M. G.; Vanni, I.; Coco, S.; Alama, A.; Grossi, F.
Novel emerging molecular targets in non-small cell lung cancer
2021-01-01 Rebuzzi, S. E.; Zullo, L.; Rossi, G.; Grassi, M.; Murianni, V.; Tagliamento, M.; Prelaj, A.; Coco, S.; Longo, L.; Bello, M. G. D.; Alama, A.; Dellepiane, C.; Bennicelli, E.; Malapelle, U.; Genova, C.
Radiomic detection of EGFR mutations in NSCLC
2020-01-01 Rossi, Giovanni; Barabino, Emanuele; Fedeli, Alessandro; Ficarra, Gianluca; Coco, Simona; Russo, Alessandro; Adamo, Vincenzo; Buemi, Francesco; Zullo, Lodovica; Dono, Mariella; De Luca, Giuseppa; Longo, Luca; Dal Bello, Maria Giovanna; Tagliamento, Marco; Alama, Angela; Cittadini, Giuseppe; Pronzato, Paolo; Genova, Carlo
Radiomic-based diagnostics in oncology: challenges toward clinical practice
2021-01-01 Barabino, Emanuele; Rossi, Giovanni; Fedeli, Alessandro; Cittadini, Giuseppe; Genova, Carlo
Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancer
2017-01-01 Genova, C.; Rossi, G.; Rijavec, E.; Biello, F.; Barletta, G.; Tagliamento, M.; Grossi, F.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients | 1-gen-2022 | Marconi, Silvia; Croce, Michela; Chiorino, Giovanna; Rossi, Giovanni; Guana, Francesca; Profumo, Aldo; Ostano, Paola; Alama, Angela; Longo, Luca; De Luca, Giuseppa; Dono, Mariella; Dal Bello, Maria Giovanna; Ponassi, Marco; Rosano, Camillo; Romano, Paolo; Cavalieri, Zita; Grassi, Massimiliano; Tagliamento, Marco; Zullo, Lodovica; Venturi, Consuelo; Dellepiane, Chiara; Mastracci, Luca; Bennicelli, Elisa; Pronzato, Paolo; Genova, Carlo; Coco, Simona | |
Afatinib and Erlotinib in the treatment of squamous-cell lung cancer | 1-gen-2018 | Tagliamento, M.; Genova, C.; Rijavec, E.; Rossi, G.; Biello, F.; Dal Bello, M. G.; Alama, A.; Coco, S.; Boccardo, S.; Grossi, F. | |
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer | 1-gen-2019 | Carbone, Federico; Grossi, Francesco; Bonaventura, Aldo; Vecchié, Alessandra; Minetti, Silvia; Bardi, Nicholas; Elia, Edoardo; Ansaldo, Anna Maria; Ferrara, Daniele; Rijavec, Erika; Dal Bello, Maria Giovanna; Biello, Federica; Rossi, Giovanni; Tagliamento, Marco; Alama, Angela; Coco, Simona; Spallarossa, Paolo; Dallegri, Franco; Genova, Carlo; Montecucco, Fabrizio | |
CIMAvax-EGF, a therapeutic non-small cell lung cancer vaccine | 1-gen-2018 | Tagliamento, M.; Rijavec, E.; Barletta, G.; Biello, F.; Rossi, G.; Grossi, F.; Genova, C. | |
Comparison between 18F-FDG-PET- and CT-based criteria in non-small cell lung cancer (NSCLC) patients treated with Nivolumab | 1-gen-2020 | Rossi, Giovanni; Bauckneht, Matteo; Genova, Carlo; Rijavec, Erika; Biello, Federica; Mennella, Simone; Dal Bello, Maria Giovanna; Cittadini, Giuseppe; Bruzzi, Paolo; Piva, Roberta; Ceriani, Valentina; Sambuceti, Gianmario; Lopci, Egesta; Morbelli, Silvia; Grossi, Francesco | |
Current state of the art and future perspectives with immunotherapy in the management of small cell lung cancer | 1-gen-2021 | Rijavec, E.; Genova, C.; Biello, F.; Rossi, G.; Indini, A.; Grossi, F. | |
Exploring Response to Immunotherapy in Non-Small Cell Lung Cancer Using Delta-Radiomics | 1-gen-2022 | Barabino, E.; Rossi, G.; Pamparino, S.; Fiannacca, M.; Caprioli, S.; Fedeli, A.; Zullo, L.; Vagge, S.; Cittadini, G.; Genova, C. | |
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy | 1-gen-2022 | Grottoli, Melania; Carrega, Paolo; Zullo, Lodovica; Dellepiane, Chiara; Rossi, Giovanni; Parisi, Francesca; Barletta, Giulia; Zinoli, Linda; Coco, Simona; Alama, Angela; Marconi, Silvia; Parodi, Monica; Orecchia, Paola; Bassi, Sara; Vitale, Massimo; Mingari, Maria Cristina; Pfeffer, Ulrich; Genova, Carlo; Pietra, Gabriella | |
Immunotherapy in Adolescents and Young Adults: What Remains in Cancer Survivors? | 1-gen-2021 | Tanda, E. T.; Croce, E.; Spagnolo, F.; Zullo, L.; Spinaci, S.; Genova, C.; Rossi, G. | |
Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer | 1-gen-2017 | Rijavec, E.; Genova, C.; Barletta, G.; Biello, F.; Rossi, G.; Tagliamento, M.; Dal Bello, M. G.; Coco, S.; Vanni, I.; Boccardo, S.; Alama, A.; Grossi, F. | |
Liquid biopsy in non-small cell lung cancer: Highlights and challenges | 1-gen-2020 | Rijavec, E.; Coco, S.; Genova, C.; Rossi, G.; Longo, L.; Grossi, F. | |
Metabolic parameters as biomarkers of response to immunotherapy and prognosis in non-small cell lung cancer (Nsclc): A real world experience | 1-gen-2021 | Monaco, L.; Gemelli, M.; Gotuzzo, I.; Bauckneht, M.; Crivellaro, C.; Genova, C.; Cortinovis, D.; Zullo, L.; Ammoni, L. C.; Bernasconi, D. P.; Rossi, G.; Morbelli, S.; Guerra, L. | |
Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds | 1-gen-2019 | Tagliamento, M.; Genova, C.; Rossi, G.; Coco, S.; Rijavec, E.; Dal Bello, M. G.; Boccardo, S.; Grossi, F.; Alama, A. | |
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature | 1-gen-2023 | Boutros, A; Bottini, A; Rossi, G; Tanda, E T; Spagnolo, F; Barletta, G; Croce, E; Fava, P; Parisi, A; De Rosa, F; Palla, M; Marconcini, R; Ferrari, M; Grandis, M; Spallarossa, P; Sarocchi, M; Arboscello, E; Del Mastro, L; Lambertini, M; Pronzato, P; Genova, C | |
New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients | 1-gen-2016 | Del Mastro, L; Rossi, Giovanni; Lambertini, M; Poggio, F; Pronzato, P | |
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer | 1-gen-2016 | Genova, C.; Rijavec, E.; Biello, F.; Rossi, G.; Barletta, G.; Dal Bello, M. G.; Vanni, I.; Coco, S.; Alama, A.; Grossi, F. | |
Novel emerging molecular targets in non-small cell lung cancer | 1-gen-2021 | Rebuzzi, S. E.; Zullo, L.; Rossi, G.; Grassi, M.; Murianni, V.; Tagliamento, M.; Prelaj, A.; Coco, S.; Longo, L.; Bello, M. G. D.; Alama, A.; Dellepiane, C.; Bennicelli, E.; Malapelle, U.; Genova, C. | |
Radiomic detection of EGFR mutations in NSCLC | 1-gen-2020 | Rossi, Giovanni; Barabino, Emanuele; Fedeli, Alessandro; Ficarra, Gianluca; Coco, Simona; Russo, Alessandro; Adamo, Vincenzo; Buemi, Francesco; Zullo, Lodovica; Dono, Mariella; De Luca, Giuseppa; Longo, Luca; Dal Bello, Maria Giovanna; Tagliamento, Marco; Alama, Angela; Cittadini, Giuseppe; Pronzato, Paolo; Genova, Carlo | |
Radiomic-based diagnostics in oncology: challenges toward clinical practice | 1-gen-2021 | Barabino, Emanuele; Rossi, Giovanni; Fedeli, Alessandro; Cittadini, Giuseppe; Genova, Carlo | |
Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancer | 1-gen-2017 | Genova, C.; Rossi, G.; Rijavec, E.; Biello, F.; Barletta, G.; Tagliamento, M.; Grossi, F. |